Gene · 2189
Papers1,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas. | Front Genet | 2022 | 36685941 | PubTator, text mining | PubMed |
| Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36612198 | PubTator, text mining | PubMed |
| Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non-small cell lung cancer. | JTCVS Open | 2022 | 36590722 | PubTator, text mining | PubMed |
| Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy. | Front Oncol | 2022 | 36531044 | PubTator, text mining | PubMed |
| Ag(II) as Spin Super-Polarizer in Molecular Spin Clusters. | J Phys Chem A | 2022 | 36521028 | PubTator, text mining | PubMed |
| Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer. | Cancers (Basel) | 2022 | 36497448 | PubTator, text mining | PubMed |
| In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells. | Front Immunol | 2022 | 36466870 | PubTator, text mining | PubMed |
Impact of the COVID-19 pandemic on utilisation of facility-based essential maternal and child health services from March to August 2020 compared with pre-pandemic March-August 2019: a mixed-methods study in North Shewa Zone, Ethiopia. | BMJ Open | 2022 | 36437538 | PubTator, text mining | PubMed |
| Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru. | Cancers (Basel) | 2022 | 36428697 | PubTator, text mining | PubMed |
| Role of Rucaparib in the Treatment of Prostate Cancer: Clinical Perspectives and Considerations. | Cancer Manag Res | 2022 | 36411744 | PubTator, text mining | PubMed |
| Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes. | Front Oncol | 2022 | 36387226 | PubTator, text mining | PubMed |
| A synonymous variant contributes to a rare Wiedemann-Rautenstrauch syndrome complicated with mild anemia via affecting pre-mRNA splicing. | Front Mol Neurosci | 2022 | 36385762 | PubTator, text mining | PubMed |
| Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36338767 | PubTator, text mining | PubMed |
| Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report. | Front Oncol | 2022 | 36338706 | PubTator, text mining | PubMed |
| Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma. | Front Genet | 2022 | 36330451 | PubTator, text mining | PubMed |
| Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data. | Nat Commun | 2022 | 36310235 | PubTator, text mining | PubMed |
| Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification. | Thorac Cancer | 2022 | 36305094 | PubTator, text mining | PubMed |
| Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF). | Medicina (Kaunas) | 2022 | 36295633 | PubTator, text mining | PubMed |
| The Manufacture of Xeno- and Feeder-Free Clinical-Grade Human Embryonic Stem Cell Lines: First Step for Cell Therapy. | Int J Mol Sci | 2022 | 36293356 | PubTator, text mining | PubMed |
| Identification of a Hypomorphic FANCG Variant in Bernese Mountain Dogs. | Genes (Basel) | 2022 | 36292578 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2189/papers?page=9